orlistat glp 1 Obesity pharmacotherapy from the @TheAACE diabetes algorithm: GLP‑1/GIP and GLP‑1 RAs produce ~10–20% weight loss with A1c reduction, while older agents like phentermine, orlistat, and naltrexone/bupropion have less efficacy and safety trade‑offs Orforglipron and Its Unique Delivery

Pathway / mechanism context BPC-157 participates in the modulation of nitric oxide signaling, influencing endothelial nitric oxide synthase activity and promoting vascular stability and angiogenesis

Duration of Use Phentermine: Short-term use GLP-1 injections: Long-term treatment GLP-1 medications are designed for ongoing weight management , not quick fixes

They negatively influence neighbor cells by secreting SASP ( In our study, ABT 263 (or UBX0101) was first tested because of its reported capacity in clearing senescent cells

Key markers include glutathione peroxidase activity, malondialdehyde (MDA), 8-hydroxydeoxyguanosine (8-OHdG), and total antioxidant capacity (TAC)